Robbins, Friedlander Seek To Lead $1.8B Biotech Sale Suit
Robbins Geller and Friedlander & Gorris told the Delaware Chancery Court they should be allowed to steer stockholder litigation that claims the $1.8 billion sale of Emisphere Technologies to Novo Nordisk...To view the full article, register now.
Already a subscriber? Click here to view full article